BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8531402)

  • 1. [Changes of the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cerebral infarction induced by the venous occlusion].
    Wakamatsu S; Banno T; Tohnai M; Oguri T
    Nihon Ronen Igakkai Zasshi; 1995; 32(8-9):566-70. PubMed ID: 8531402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic activity and platelet release reaction in essential hypertension.
    Keskin A; Tombuloglu M; Büyükkeçeci F
    Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke.
    Zhuang P; Wo D; Xu ZG; Wei W; Mao HM
    J Clin Neurosci; 2015 Jul; 22(7):1123-7. PubMed ID: 26002716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T; Tamura Y; Fukuda N; Ito S
    Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet function and fibrinolytic activity during rest and exercise in borderline hypertensive patients.
    Gleerup G; Vind J; Winther K
    Eur J Clin Invest; 1995 Apr; 25(4):266-70. PubMed ID: 7601202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
    Li F; Zhang G; Zhao W
    Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets.
    Simpson AJ; Gray RS; Moore NR; Booth NA
    Br J Haematol; 1997 Apr; 97(1):208-13. PubMed ID: 9136967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) by the interferon treatment for chronic hepatitis C].
    Hayashi T; Ro S; Kamogawa A; Kobayashi Y; Suzuki Y; Imai M; Okuse C; Ozaki M; Iwabuchi S; Murayama M
    Rinsho Byori; 1995 Sep; 43(9):948-52. PubMed ID: 7474459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the fibrinolytic system components during acute myocardial infarction.
    Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
    Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the fibrinolytic activity in hypertension and acute cerebral infarction].
    Guan KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):150-2, 186-7. PubMed ID: 8243228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).
    Seeber C; Hiller E; Holler E; Kolb HJ
    Thromb Res; 1992 May; 66(4):373-83. PubMed ID: 1412203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of red wine on the fibrinolytic system and the cellular activation reactions before and after exercise.
    Johansen KM; Skorpe S; Olsen JO; Osterud B
    Thromb Res; 1999 Dec; 96(5):355-63. PubMed ID: 10605950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet function and fibrinolytic activity in patients with bronchial asthma.
    Tutluoglu B; Gurel CB; Ozdas SB; Musellim B; Erturan S; Anakkaya AN; Kilinc G; Ulutin T
    Clin Appl Thromb Hemost; 2005 Jan; 11(1):77-81. PubMed ID: 15678276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.